Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: LDR vs. HDR Brachytherapy for Prostate Cancer [NA]

View source ↗

Summary

A clinical trial update notes an active not recruiting study comparing low-dose-rate (LDR) versus high-dose-rate (HDR) brachytherapy for prostate cancer (NCT034…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDR brachytherapy
  • LDR brachytherapy

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING